SEC Form 4 · accession 0001078782-18-000298
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Mar 12, 2018
Accepted (ET)
Mar 12, 2018 · 2:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2018 | P | 20,000 | $0.11 | A | 14,510,831 | D | |
| Common Stock | Mar 7, 2018 | P | 57,000 | $0.11 | A | 14,567,831 | D | |
| Common Stock | Mar 8, 2018 | P | 39,000 | $0.11 | A | 14,606,831 | D |
Table II — derivative securities
No Table II lines on this filing.